logo
13:39 Feb 26

Windlas Biotech Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
760.95
+2.30 (+0.30%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Windlas Biotech Ltd. Financials

Windlas Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
760.95
+2.30 (+0.30%)
13:39 Feb 26
Quality
image/svg+xml

54/100
Medium Financial Strength

Valuation
image/svg+xml

41/100
Mid Valuation

Technical

31/100
Technically Bearish

Strength

5

Weakness

5

Opportunity

0

Threats

0

11.95 %

ROE %

7.94 %

ROA %

31.85

EPS

241.30

BVPS

7.95 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
427.6 465.93 513.08 630.96 759.88
Operating Expenses +
372.91 413.5 452.86 552.79 665.78
Raw Material
270.74 307.56 340.71 386.59 493.38
Increase Decrease in Cost
3.67 -4.74 -15.27 9.59 -21.52
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
58.32 63.41 70.32 87.46 122.92
Miscellaneous Expenses
40.18 47.27 57.1 69.15 71
Operating Profit
54.69 52.43 60.22 78.17 94.1
Other Income
3.09 6.71 9.96 13.47 18.02
Depreciation
12.96 12.15 12.36 13.44 27.98
Interest
1.29 1.42 0.79 1.1 4.38
Profit before tax and exceptio..
43.53 45.56 57.04 77.09 79.76
Exceptional Items
-21.62 0 0 0 0
PBT
21.91 45.56 57.04 77.09 79.76
Provision for Taxation
6.17 7.48 14.41 18.9 18.76
Net Profit
15.74 38.09 42.63 58.19 60.99
NET Profit after MI
15.83 38.09 42.63 57.94 60.44
EPS
8.7 18.58 19.7 27.97 28.87
Operating Profit Margin (%)
12.79 11.25 11.74 12.39 12.38
Net Profit Margin (%)
3.7 8.18 8.31 9.18 7.95

Windlas Biotech Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 62.00 62.00 62.30 62.30 62.50 62.50
FII 0.90 1.10 1.40 1.50 1.60 2.00
Public 11.50 11.50 11.30 10.90 10.20 9.60
Others 25.60 25.40 25.00 25.30 25.70 25.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: